The company has received the tentative approval from the USFDA to market Colchicine tablets USP in the strength of 0.6 mg, Zydus Cadila said in a statement.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2CRRMFY
via IFTTT
Zydus Cadila gets USFDA nod for generic gout attacks drug
The company has received the tentative approval from the USFDA to market Colchicine tablets USP in the strength of 0.6 mg, Zydus Cadila said in a statement.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2CRRMFY
via IFTTT
0 comments:
Post a Comment